<DOC>
	<DOCNO>NCT00238511</DOCNO>
	<brief_summary>This trial follow-on trial preceeding double-blind , placebo control trial include patient least moderate pain due postherpetic neuralgia . It conduct six site Germany clinically finalize . The patient successfully complete mentioned trial postherpetic neuralgia , investigator 's opinion , would benefit long-term administration Lacosamide . After 1-week run-in phase patient uptitrated optimal dose continue maintenance phase . Dose adjustment allow throughout trial.The change pain measure daily well interference pain sleep general activity . As per protocol trial terminate two year treatment .</brief_summary>
	<brief_title>An Open-Label Follow-on Trial Assess Long-Term Safety Efficacy Oral SPM 927 Subjects With Postherpetic Neuralgia ( PHN )</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Postherpetic Neuralgia Does benefit long term treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>